Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 6-'We have a new weapon': Europe rolls out vaccines in bid to slay COVID

Sun, 27th Dec 2020 10:17

(Adds comment from Pfizer, BioNTech)

* Goal is to offer vaccine to all adults through 2021

* 'Thank God,' says first recipient in Spain, 96

* Delays in some German cities over cooling concerns

* Urgency as new virus variants crop up

By Isla Binnie and Giselda Vagnoni

MADRID/ROME, Dec 27 (Reuters) - Europe launched a mass
COVID-19 vaccination drive on Sunday with pensioners and medics
lining up to get the first shots to see off a pandemic that has
crippled economies and claimed more than 1.7 million lives
worldwide.

"Thank God," 96-year-old Araceli Hidalgo said as she became
the first person in Spain to have a vaccine at her care home in
Guadalajara, near the capital Madrid.

"Let's see if we can make this virus go away."

In Italy, the first country in Europe to record significant
numbers of infections, 29-year-old nurse Claudia Alivernini was
one of three medical staff at the head of the queue for the shot
developed by Pfizer and BioNTech.

"It is the beginning of the end ... it was an exciting,
historic moment," she said at Rome's Spallanzani hospital.

The region of 450 million people is trying to catch up with
the United States and Britain, which have already started
vaccinations using the Pfizer shot.

The European Union is due to receive 12.5 million doses by
the end of the year, enough to vaccinate 6.25 million people
based on the two-dose regimen. The companies are scrambling to
meet global demand and aim to make 1.3 billion shots next year.

The bloc has secured contracts with a range of drugmakers
besides Pfizer, including Moderna and AstraZeneca
, for a total of more than two billion vaccine doses and
has set a goal for all adults to be inoculated during 2021.

With surveys pointing to high levels of hesitancy towards
the vaccine in countries from France to Poland, leaders of the
27-country European Union are promoting it as the best chance of
getting back to something like normal life next year.

"We have a new weapon against the virus: the vaccine. We
must stand firm, once more," tweeted French President Emmanuel
Macron, who tested positive for the coronavirus this month and
left quarantine on Christmas Eve.

"Completely painless," Greek Prime Minister Kyriakos said
after getting his vaccination in a hospital in Athens.

COOLING CONCERNS

The distribution of the shot presents tough challenges as
the vaccine uses new mRNA technology and must be stored at
ultra-low temperatures of about -70 degrees Celsius (-112°F).

In Germany, the campaign faced delays in several cities
after a temperature tracker showed that about 1,000 shots may
not have been kept cold enough during transit.

Pfizer said that BioNtech was responsible for the shipment
to the 25 German distribution centres and that the federal
states and local authorities were responsible for the shipment
to the vaccination centres and the mobile vaccination teams.

"This is where the variations in temperature occurred. We
are in contact with many authorities to provide advice, however
it is up to them how to proceed", a Pfizer spokesperson said.

A BioNTech spokeswoman said: "We are looking into the case
and are in contact with the relevant districts," echoing that
while BioNtech provided advice, it was up to the German
authorities to decide how to proceed.

The Pfizer shots being used in Europe were shipped from its
factory in Puurs, Belgium, in specially designed containers
filled with dry ice. They can be stored for up to six months at
Antarctic winter temperatures, or for five days at 2C to 8C, a
type of refrigeration commonly available at hospitals.

In Italy, temporary solar-powered healthcare pavilions
designed to look like five-petalled primrose flowers - a symbol
of spring - sprouted in town squares as the vaccination drive
kicked off.

Portugal has been establishing separate cold storage units
for its Atlantic archipelagos of Madeira and the Azores.

At the Santa Maria hospital in Portugal's capital Lisbon,
Pedro Pires waited for a shot with other nurses at the end of an
overnight shift.

"It has been tiring ... a lot of work," he told Reuters.

Branka Anicic, an 81-year-old resident of a care home in
Zagreb, became the first person to get a shot in Croatia. "I'm
happy I will now be able to see my great-grandchildren," she
said.

"It will change the lives of everyone in the world," said an
elderly passerby in Paris who gave her name as Anaik.

German pilot Samy Kramer celebrated the vaccination campaign
by tracing out a giant syringe in the sky. He flew 200 km (125
miles), following a syringe-shaped route that showed up on
internet site flightradar24.

'FIRST MAN ON THE MOON'

The vaccination drive is all the more urgent because of the
concern around new variants of the virus linked to a rapid
expansion of cases in Britain and South Africa.

"We know that the pandemic won't just disappear as of today,
but the vaccine is the beginning of the victory over the
pandemic, the vaccine is a 'game changer'. We have always know
that, and today is the first day of this new phase," Austrian
Chancellor Sebastian Kurz.

Over the past week, cases of the UK variant have been
detected in Australia, Hong Kong and in several European
countries, mostly recently Sweden, France, Norway and Portugal's
island of Madeira. So far, scientists say there is no evidence
to suggest the vaccines developed will be any less effective
against the new variants.

While Europe has some of the best-resourced healthcare
systems in the world, the sheer scale of the effort means some
countries are calling on retired medics to help while others
have loosened rules for who is allowed to give the injections.

Beyond hospitals and care homes, sports halls and convention
centres left vacant by lockdown restrictions will become venues
for mass inoculations.

Vaccinations also started in Norway, which is not a member
of the bloc but part of the EU's drive.

"I feel like a historical figure ... almost like the first
man on the Moon," said care home resident Svein Andersen, 67, as
he received the country's first shot in the capital Oslo.

After European governments were criticised for failing to
work together to counter the spread of the virus in early 2020,
the goal this time is to ensure that there is equal access to
the vaccines across the region.

But even then, Hungary on Saturday jumped the gun on the
official roll-out by administering shots to frontline workers at
hospitals in the capital Budapest. The Netherlands said it will
not start vaccinating until Jan. 8.

Slovakia also went ahead with some inoculations of
healthcare staff on Saturday and in Germany, a small number of
people at a care home were inoculated a day early too.

"We don't want to waste that one day that the vaccine loses
shelf life," Karsten Fischer, from the pandemic staff of the
Harz district in the German state of Saxony-Anhalt, told
broadcaster MDR.

(Additional reporting by Catarina Demony in Lisbon, Silke
Koltrowitz in Vienna, Robert Muller in Prague, Tsvetelia Tsolova
in Sofia, Igor Ilic in Zagreb, Nerijus Adomaitis in oslo,
Michele Kambas in Athens and Benoit Van Overstraeten in Paris;
Writing by Mark John and Andrew Heavens; Editing by David Clarke
and Nick Macfie)

More News
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.